Download video

Transplant Outcomes in Older Adults with MDS and AML 2021

2.7K views

BMT InfoNet

3 years ago

Transplant Outcomes in Older Adults with MDS and AML 2021

Transplant Outcomes in Older Adults with MDS and AML 2021

Transplant Outcomes in Older Adults with MDS and AML 2021
57:15
Transplant Outcomes in Older Adults with MDS and AML 2021
by BMT InfoNet
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How 2021
57:44
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How 2021
by BMT InfoNet
Haplo-SCT for older patients with AML\/HR-MDS: should age be a barrier to transplantation?
2:22
Haplo-SCT for older patients with AML\/HR-MDS: should age be a barrier to transplantation?
by VJHemOnc – Video Journal of Hematology \& HemOnc
Transplant outcomes of AML\/HR-MDS patients treated with sabatolimab plus HMA
2:10
Transplant outcomes of AML\/HR-MDS patients treated with sabatolimab plus HMA
by VJHemOnc – Video Journal of Hematology \& HemOnc
2021 West Oncology APP | Treatment Options for Elderly AML\/MDS Patients
19:37
2021 West Oncology APP | Treatment Options for Elderly AML\/MDS Patients
by Total Health | Oncology
RIC transplant in CR1 for older AML patients
5:57
RIC transplant in CR1 for older AML patients
by VJHemOnc – Video Journal of Hematology \& HemOnc
How to improve transplant outcomes in MDS?
0:53
How to improve transplant outcomes in MDS?
by VJHemOnc – Video Journal of Hematology \& HemOnc
Allogeneic transplant for older AML patients - who, when and how
3:16
Allogeneic transplant for older AML patients - who, when and how
by VJHemOnc – Video Journal of Hematology \& HemOnc
Transplant Options for Patients with AML 2019
1:13:17
Transplant Options for Patients with AML 2019
by BMT InfoNet
Transplant and CAR T-cell Therapy for Older Adults
55:29
Transplant and CAR T-cell Therapy for Older Adults
by BMT InfoNet
Can Transplantation improve survival rates for older patients with Higher risk MDS?
21:44
Can Transplantation improve survival rates for older patients with Higher risk MDS?
by MDS Foundation, Inc.
Dr. Rizzo on Impact of Age on Survival Outcomes in MDS After HCT
1:28
Dr. Rizzo on Impact of Age on Survival Outcomes in MDS After HCT
by OncLive
The Role of BMT in Treatment-Related MDS and AML
6:50
The Role of BMT in Treatment-Related MDS and AML
by AAMDSIF
Outcomes of alloHSCT in TP53-mutated AML and MDS
1:40
Outcomes of alloHSCT in TP53-mutated AML and MDS
by VJHemOnc – Video Journal of Hematology \& HemOnc
8th Seattle Patient Conference MDS Transplant Options
25:41
8th Seattle Patient Conference MDS Transplant Options
by AAMDSIF
The impact of donor KIR genotypes on alloSCT outcomes in AML\/MDS, and the value of biobanks
10:40
The impact of donor KIR genotypes on alloSCT outcomes in AML\/MDS, and the value of biobanks
by VJHemOnc – Video Journal of Hematology \& HemOnc
Stem Cell Transplant Approaches to MDS
24:51
Stem Cell Transplant Approaches to MDS
by HMP Education
Myeloablative conditioning regimen with PTCy in elderly patients with AML and MDS
3:23
Myeloablative conditioning regimen with PTCy in elderly patients with AML and MDS
by VJHemOnc – Video Journal of Hematology \& HemOnc
New salvage treatment for AML\/MDS after allogeneic transplant: the VIOLA trial
2:34
New salvage treatment for AML\/MDS after allogeneic transplant: the VIOLA trial
by VJHemOnc – Video Journal of Hematology \& HemOnc